» Articles » PMID: 34660276

MRI-Based Grading of Clear Cell Renal Cell Carcinoma Using a Machine Learning Classifier

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Oct 18
PMID 34660276
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To develop a machine learning (ML)-based classifier for discriminating between low-grade (ISUP I-II) and high-grade (ISUP III-IV) clear cell renal cell carcinomas (ccRCCs) using MRI textures.

Materials And Methods: We retrospectively evaluated a total of 99 patients (with 61 low-grade and 38 high-grade ccRCCs), who were randomly divided into a training set ( = 70) and a validation set ( = 29). Regions of interest (ROIs) of all tumors were manually drawn three times by a radiologist at the maximum lesion level of the cross-sectional CMP sequence images. The quantitative texture analysis software, MaZda, was used to extract texture features, including histograms, co-occurrence matrixes, run-length matrixes, gradient models, and autoregressive models. Reproducibility of the texture features was assessed with the intra-class correlation coefficient (ICC). Features were chosen based on their importance coefficients in a random forest model, while the multi-layer perceptron algorithm was used to build a classifier on the training set, which was later evaluated with the validation set.

Results: The ICCs of 257 texture features were equal to or higher than 0.80 (0.828-0.998. Six features, namely Kurtosis, 135dr_RLNonUni, Horzl_GLevNonU, 135dr_GLevNonU, S(4,4)Entropy, and S(0,5)SumEntrp, were chosen to develop the multi-layer perceptron classifier. A three-layer perceptron model, which has 229 nodes in the hidden layer, was trained on the training set. The accuracy of the model was 95.7% with the training set and 86.2% with the validation set. The areas under the receiver operating curves were 0.997 and 0.758 for the training and validation sets, respectively.

Conclusions: A machine learning-based grading model was developed that can aid in the clinical diagnosis of clear cell renal cell carcinoma using MRI images.

Citing Articles

Role of AI and Radiomic Markers in Early Diagnosis of Renal Cancer and Clinical Outcome Prediction: A Brief Review.

Shehata M, Abouelkheir R, Gayhart M, van Bogaert E, Abou El-Ghar M, Dwyer A Cancers (Basel). 2023; 15(10).

PMID: 37345172 PMC: 10216706. DOI: 10.3390/cancers15102835.

References
1.
Pedrosa I, Chou M, Ngo L, Baroni R, Genega E, Galaburda L . MR classification of renal masses with pathologic correlation. Eur Radiol. 2007; 18(2):365-75. DOI: 10.1007/s00330-007-0757-0. View

2.
Evelonn E, Degerman S, Kohn L, Landfors M, Ljungberg B, Roos G . DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC). Tumour Biol. 2016; 37(8):10219-28. DOI: 10.1007/s13277-016-4893-5. View

3.
Rosenkrantz A, Niver B, Fitzgerald E, Babb J, Chandarana H, Melamed J . Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol. 2010; 195(5):W344-51. DOI: 10.2214/AJR.10.4688. View

4.
Purkayastha S, Zhao Y, Wu J, Hu R, McGirr A, Singh S . Differentiation of low and high grade renal cell carcinoma on routine MRI with an externally validated automatic machine learning algorithm. Sci Rep. 2020; 10(1):19503. PMC: 7658976. DOI: 10.1038/s41598-020-76132-z. View

5.
Zhou H, Vallieres M, Bai H, Su C, Tang H, Oldridge D . MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Neuro Oncol. 2017; 19(6):862-870. PMC: 5464433. DOI: 10.1093/neuonc/now256. View